Status
Conditions
Treatments
About
20 healthy subjects will be split into 4 groups. Each group will receive one of the following tDCS montages : anodal, bilateral, cathodal or placebo Subjects will receive 2mA for 20 mins of their attributed tDCS. The evaluation is a maximal strength test measured with the IOPI and will take place prior to, immediately following and 30 minutes after stimulation
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Stephen Bornheim, Msc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal